Up a level |
Poh, Xuan Ying, Tan, Chee Wah, Lee, I Russel, Chavatte, Jean-Marc, Fong, Siew-Wai, Prince, Tessa ORCID: 0000-0002-8796-2629, Hartley, Catherine, Yeoh, Aileen Ying-Yan, Rao, Suma, Chia, Po Ying et al (show 16 more authors)
(2022)
Antibody response of heterologous vs homologous mRNA vaccine boosters against the SARS-CoV-2 Omicron variant: interim results from the PRIBIVAC study, A Randomized Clinical Trial.
Clinical Infectious Diseases, 75 (12).
pp. 2088-2096.
Lim, Jackwee, Puan, Kia Joo, Wang, Liang Wei, Teng, Karen Wei Weng, Loh, Chiew Yee, Tan, Kim Peng, Carissimo, Guillaume, Chan, Yi-Hao, Poh, Chek Meng, Lee, Cheryl Yi-Pin et al (show 23 more authors)
(2021)
Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals.
FRONTIERS IN IMMUNOLOGY, 12.
710217-.
Rouers, Angeline, Wong, Nathan, Goh, Yun Shan, Torres-Ruesta, Anthony, Tay, Matthew Zirui, Chang, Zi Wei, Fong, Siew-Wai, Neo, Vanessa, Kam, Isaac Kai Jie, Yeo, Nicholas Kim-Wah et al (show 24 more authors)
(2023)
Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters.
JOURNAL OF MEDICAL VIROLOGY, 95 (1).
e28258-.
Poh, Xuan Ying, Lee, I Russel, Lim, Clarissa, Teo, Jefanie, Rao, Suma, Chia, Po Ying, Ong, Sean WX, Lee, Tau Hong, Lin, Ray JH, Ng, Lisa FP ORCID: 0000-0003-4071-5222 et al (show 6 more authors)
(2022)
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].
TRIALS, 23 (1).
498-.